Intrinsic Value

538964 doesn't have a meaningful market cap.

The intrinsic value of Mercury Laboratories Ltd (538964) under the Base Case is 818.54 INR per share. Compared with the current market price of 777.7 INR, the stock appears Undervalued by 5% .

The intrinsic value is calculated using the DCF method. The model assumes operating margin rises from 7.4% last year to 8.3% by 2032, above its five-year average of 7.4%. If operating margin stayed at its five-year average of 7.4%, the estimate would be about ₹726.

Do our valuations actually work? See backtest results .

MERCURYLAB Intrinsic Value
₹818.54
Undervaluation 5%
Intrinsic Value
Price ₹777.7
Alert me when MERCURYLAB is below its intrinsic value
Today ₹654.83 · 15.8% below the current price

MERCURYLAB is more expensive than usual. Still undervalued, but the discount was larger on 92% of days in the past 5 years.

Alternatives to MERCURYLAB

Fundamental Analysis

What Mercury Laboratories Does

Mercury Laboratories Ltd. engages in the production and sale of pharmaceuticals and its related products. The company is headquartered in Vadodara, Gujarat. The company went IPO on 2015-02-23. The firm is engaged in the manufacturing of pharmaceuticals, medicinal drugs and formulations. The Company’s products include Analgesic, Anti-inflammatory, Anti-pyretic, Anthelmintic, Antibiotic, Anti-coagulant, Anti- platelet, Bleeding agents, Anti-fungal, Anti-hypertensive drugs, Anti-malarial drugs, Cardiovascular System, Central Nervous System, Eye, Gastro-intestinal system, Hypoglycemic…

Headquarters
India IN
IPO date
Feb 23, 2015
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Mercury Laboratories Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one MERCURYLAB stock?

The intrinsic value for Mercury Laboratories Ltd (538964) under the Base Case is 818.54 INR.

Is MERCURYLAB stock undervalued or overvalued?

Compared with the current market price of 777.7 INR, the stock appears Undervalued by 5% .

Back to Top